ISSN: 7027-2221

Author : J. Al-Hamdani, Kadhum

Oxidative stress in the sera and seminal plasma of the infertile subjects in Babylon governorate

Kadhum J. Al-Hamdani; Tariq H. Al-Khyatt

karbala journal of pharmaceutical sciences, Volume 1, Issue 1, Pages 33-42

This study was conducted to demonstrate the effect of serum and seminal oxidative stress (OS) on male infertility with different infertility potentials. To achieve this aim, the levels of malondialdehyde (MDA), glutathione (GSH) and catalase activity were determined by the spectrophotometric methods in the sera and the seminal plasma of 75 infertile males divided to: 25 azoospermics with age range (25-45 yr), 25 asthenozoospermics with age range (24-45 yr) and 25 oligozoospermics with age range (23-41 yr). Twenty five healthy fertile male with age range (22-45 yr) used as controls. The results indicated a significant increase in the seminal and serum levels of MDA in azoospermic group (p< 0.05, p<0.001 respectively), asthenozoospermic group (p<0.001 both) and oligozoospermic group (p<0.001 both). While the levels of seminal and serum GSH are significantly decreased in azoospermic group (p<0.01, p<0.001 respectively), asthenozoospermic group (p<0.01, p<0.001 respectively) and oligozoospermic group (p<0.001, p<0.05 respectively). Also the levels of seminal and serum catalase activity significantly decreased in azoospermic group (p<0.05, p<0.001 respectively), asthenozoospermic group (p<0.01, p<0.05 respectively) and oligozoospermic group (p<0.01 both). The obtained results showed a positive correlation between serum MDA with the seminal MDA but negative correlation with the seminal GSH and catalase activity, while the positive correlation between serum and seminal antioxidants has not been demonstrated in all study groups. The study reveals a negative correlation between OS and good seminal fluid analysis parameters. As a conclusion to this study, serum and seminal OS is involved in the pathogenesis of male infertility confirming that the use of antioxidant therapy can improve OS-induced male infertility.